Abbott Laboratories (Pakistan) Limited (ABOT) financial ratios

Abbott Laboratories (Pakistan) Limited earned a net margin of 10.6% in FY2025 against a five-year average of 7.8% (Pharmaceuticals median 9.4%). Return on equity was 28.8%, compared with a sector median of 21.7%. The current ratio stood at 2.32× and debt was 1.5% of equity. Cash took about 82 days to cycle through receivables, inventory and payables.

FY2025 vs the Pharmaceuticals median

Gross margin: 35.5%; Sector median 37.0%
Operating margin: 17.5%; Sector median 17.3%
Net margin: 10.6%; Sector median 9.4%
Return on equity (ROE): 28.8%; Sector median 21.7%
Return on assets (ROA): 18.9%; Sector median 11.7%
Current ratio: 2.32×; Sector median 1.79×
Debt to equity: 1.5%; Sector median 5.8%
Asset turnover: 1.79×; Sector median 1.26×
Dividend payout ratio: 49.2%; Sector median 32.8%

Median of the 14 companies in the sector with the figure for their latest fiscal year.

ABOT financial ratios (annual) (Rs mn)
Rs mn	FY2025 Jan – Dec 2025	FY2024 Jan – Dec 2024	FY2023 Jan – Dec 2023	FY2022 Jan – Dec 2022	FY2021 Jan – Dec 2021	FY2020 Jan – Dec 2020	FY2019 Jan – Dec 2019	FY2018 Jan – Dec 2018	FY2017 Jan – Dec 2017	FY2016 Jan – Dec 2016	FY2015 Jan – Dec 2015	FY2014 Jan – Dec 2014	FY2013 Jan – Dec 2013	FY2012 Jan – Dec 2012	FY2011 Jan – Dec 2011	FY2010 Jan – Dec 2010	FY2009 Dec 2008 – Nov 2009	FY2008 * Dec 2007 – Nov 2008	FY2007 * Dec 2006 – Nov 2007	FY2006 Dec 2005 – Nov 2006
Profitability
Gross margin	35.5%	29.3%	21.3%	29.5%	37.8%	34.6%	28.3%	33.0%	38.7%	40.1%	38.9%	38.3%	38.5%	37.5%	36.0%	33.5%	27.5%	29.9%	41.4%	41.2%
EBITDA margin	20.0%	15.7%	8.6%	15.3%	21.3%	20.4%	11.8%	17.2%	23.5%	24.6%	24.0%	21.9%	22.7%	21.2%	19.8%	28.7%	23.4%	24.8%	36.1%	27.4%
Operating margin	17.5%	13.0%	5.8%	12.4%	18.3%	17.2%	8.4%	14.7%	21.2%	22.3%	21.7%	19.7%	20.4%	19.0%	17.6%	26.4%	20.9%	22.0%	33.3%	24.0%
Pre-tax margin	17.9%	13.2%	3.7%	12.5%	19.8%	17.7%	8.3%	14.6%	22.4%	23.9%	23.6%	21.9%	21.4%	19.8%	18.3%	15.8%	10.4%	7.6%	26.5%	23.9%
Net margin	10.6%	7.7%	0.5%	6.1%	14.0%	12.9%	4.3%	9.1%	16.1%	17.2%	16.9%	14.3%	14.7%	13.7%	12.7%	10.7%	7.2%	4.8%	18.0%	16.9%
Effective tax rate	41.0%	42.0%	87.2%	51.1%	29.1%	27.4%	48.2%	38.0%	28.0%	28.0%	28.4%	34.8%	31.4%	30.7%	30.7%	32.4%	30.5%	36.9%	32.1%	29.3%
Returns
Return on equity (ROE)	28.8%	24.9%	1.5%	17.4%	36.2%	31.3%	9.8%	19.5%	29.1%	29.2%	30.1%	28.7%	32.7%	35.1%	36.1%	32.9%	17.9%	9.5%	29.9%	20.4%
Return on assets (ROA)	18.9%	14.1%	0.7%	9.6%	22.3%	19.9%	6.3%	13.7%	22.8%	23.6%	23.7%	22.6%	24.7%	25.0%	24.9%	21.9%	12.2%	7.1%	24.4%	17.1%
Return on invested capital (ROIC)	28.6%	24.9%	1.5%	17.3%	35.3%	30.4%	9.7%	19.4%	29.1%	29.2%	30.1%	28.7%	32.7%	35.1%	36.1%	32.9%	17.9%	9.5%	29.9%	20.4%
Liquidity
Current ratio	2.32×	1.99×	1.38×	1.49×	1.97×	2.30×	1.80×	1.96×	2.98×	4.61×	3.73×	3.86×	3.56×	2.71×	2.42×	2.19×	2.03×	2.50×	3.55×	4.76×
Quick ratio	1.34×	1.03×	0.59×	0.89×	1.22×	1.53×	0.88×	1.27×	2.19×	3.31×	2.81×	2.76×	2.27×	1.66×	1.26×	0.97×	0.94×	1.24×	1.95×	3.01×
Leverage
Debt to equity	1.5%	0.2%	0.9%	1.4%	1.3%	5.2%	2.9%	1.6%	0.0%	—	—	—	—	—	—	—	—	—	0.0%	0.1%
Debt to capital	1.5%	0.2%	0.9%	1.4%	1.3%	5.0%	2.8%	1.6%	0.0%	—	—	—	—	—	—	—	—	—	0.0%	0.1%
Debt to assets	1.0%	0.1%	0.4%	0.7%	0.8%	3.3%	1.8%	1.1%	0.0%	—	—	—	—	—	—	—	—	—	0.0%	0.1%
Assets to equity	1.53×	1.77×	2.00×	1.81×	1.62×	1.58×	1.54×	1.43×	1.27×	1.24×	1.27×	1.27×	1.33×	1.41×	1.45×	1.50×	1.47×	1.34×	1.23×	1.20×
Efficiency
Asset turnover	1.79×	1.83×	1.57×	1.58×	1.59×	1.55×	1.47×	1.51×	1.42×	1.37×	1.40×	1.58×	1.68×	1.82×	1.96×	2.04×	1.69×	1.46×	1.36×	1.01×
Receivable days days	24	27	25	21	22	28	29	21	17	16	14	17	22	25	25	25	25	26	31	39
Inventory days days	92	93	93	84	84	92	93	75	83	88	85	87	93	95	100	105	104	116	129	173
Payable days days	34	54	70	56	42	36	44	44	31	24	20	16	20	19	17	20	20	19	22	26
Cash conversion cycle days	82	66	48	49	64	84	78	52	70	79	78	88	95	101	108	109	109	122	137	186
Dividends
Dividend payout ratio	49.2%	18.7%	0.0%	48.9%	65.6%	86.3%	56.5%	72.7%	93.1%	97.4%	81.9%	27.1%	27.1%	32.8%	35.7%	41.6%	192.9%	142.3%	148.7%	21.7%
Earnings retention rate	0.51×	0.81×	1.00×	0.51×	0.34×	0.14×	0.44×	0.27×	0.07×	0.03×	0.18×	0.73×	0.73×	0.67×	0.64×	0.58×	(0.93×)	(0.42×)	(0.49×)	0.78×

Ratios as reported for each fiscal year; returns are on average equity / assets. Debt ratios are percentages; turnover in times; working-capital measures in days.

ABOT: frequently asked questions

What is ABOT's EPS?

Abbott Laboratories (Pakistan) Limited reported basic earnings per share of Rs 81.37 for FY2025 (Jan – Dec 2025). Over the trailing twelve months (TTM to Jun 2026) EPS was Rs 87.47.

What is ABOT's P/E ratio?

At the closing price of Rs 944.39 on 16 Oct 2026, ABOT trades at a P/E of 10.8× based on EPS of Rs 87.47 (TTM to Jun 2026).

Does ABOT pay dividends?

Yes. Abbott Laboratories (Pakistan) Limited declared a dividend of Rs 40.00 per share for FY2025. It has paid a dividend in each of the last 2 years. At Rs 944.39 that is a dividend yield of 4.2%.

What was ABOT's revenue and profit in FY2025?

Abbott Laboratories (Pakistan) Limited reported revenue of Rs 75.4 bn and profit attributable to shareholders of Rs 8.0 bn for FY2025 (Jan – Dec 2025).

What is ABOT's book value per share?

Abbott Laboratories (Pakistan) Limited's book value per share was Rs 323.04 at the end of FY2025. The shares trade at 2.88× book value.

Information only, not investment advice.